TAL1 Antikörper (full length)
Kurzübersicht für TAL1 Antikörper (full length) (ABIN7879110)
Target
Alle TAL1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- full length
-
Verwendungszweck
- TAL1 Antibody / T-cell acute lymphocytic leukemia protein 1
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- A recombinant human full-length TAL1 protein was used as the immunogen for the TAL1 antibody.
-
Isotyp
- IgG1, kappa
-
-
-
-
Applikationshinweise
- Optimal dilution of the TAL1 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the TAL1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- TAL1 (T-Cell Acute Lymphocytic Leukemia 1 (TAL1))
-
Andere Bezeichnung
- TAL1
-
Hintergrund
- Activation of TAL1 characterizes up to 60 % of cases of human T cell acute lymphoblastic leukemia, making it the most frequent gain-of-function mutation observed in this disorder. TAL1 (also designated SCL) is a serine phosphoprotein and basic helix-loop-helix transcription factor known to regulate embryonic hematopoiesis. This transcription factor binds as a heterodimer with E2A and HEB/HTF4 to a nucleotide sequence motif termed the E-box. In addition, leukemogenesis is accelerated dramatically by transgenic co-expression of TAL1 and the catalytic subunit of casein kinase IIHLH transcription factors.
-
UniProt
- P17542
-
Pathways
- Stem Cell Maintenance
Target
-